Vyriad Expands Clinical Study of Oncolytic Virus Therapy in Bladder Cancer Patients ROCHESTER, Minn., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Vyriad, Inc. announced today the addition of new clinical sites in its ongoing clinical study evaluating an intravesical oncolytic measles virus...